After an incorrect dose of a chemotherapy drug for Crohn's disease caused Anne Webster's bone marrow to shut down, she decided that, if she survived, she'd write about her experience.
New Orleans bluesman Anders Osborne is launching a program to help musicians and others in the industry stay sober in work environments that are often centered around drugs and alcohol.
Men are more likely than women to put off going to the doctor. Hispanic men can face complications of culture, language and cost that make that even more likely.
Research in epilepsy has found a key to why small pulses of electricity to the brain sometimes help and sometimes hurt a failing memory. Brains hurt by physical trauma or dementia might benefit, too.
Max Baker got treatment for his opioid dependency and kicked the habit. He'd been clean for more than a year when a car accident and subsequent surgery returned him to addiction's spiral.
Researchers found that a protein in human umbilical cord plasma improved learning and memory in older mice, but there's no indication it would work in people.
Many insurers have required that adults with hepatitis C be very sick before they can get access to expensive drug treatment. But Medicaid has special rules that may get kids and teens access sooner.
The federal government wants to require that private accreditors release reports of problems they find during hospital inspections. Right now, the reports are kept confidential.
An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer, an analysis by Kaiser Health News reveals.
Treating addiction is expensive and patients often relapse. A new company is offering better results at a price that's lower in the long run — and clients get treatment right at home.